Keynote lectures will be delivered by a distinguished international faculty, while a large number of selected free communications will report new data from basic research laboratories and clinical centers around the globe.

The program will use a bench to bedside approach and include sessions on molecular mechanisms, gene therapy, cell therapy and angiogenesis, stem cells and myocardial regeneration, epidemiology and prevention, pharmacology and clinical trials. We will discuss new frontiers in interventional cardiology and new approaches to the surgical management of coronary disease.